VTR · Ventas, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Common stock shares settled under equity forward sales agreements year to date | 31.4M | 2026 year to date | — |
| Gross proceeds from settled equity forward sales agreements year to date | 2.6B | 2026 year to date | — |
| Liquidity | 4.9B | Q2 2026 | — |
|
|
|||
| Net Debt-to-Further Adjusted EBITDA non-GAAP | 4.7 | Q2 2026 | — |
| Senior housing investments closed | 2.2B | Q2 2026 | — |
| Senior housing investments closed year to date | 3.4B | 2026 year to date | — |
| SHOP RevPOR growth non-GAAP | 5% | Q2 2026 | — |
|
|
|||
| SHOP Same-Store Cash NOI growth non-GAAP | 16% | Q2 2026 | — |
| SHOP Same-Store Cash NOI margin expansion non-GAAP | 210 | Q2 2026 | — |
| SHOP Same-Store Cash Operating Revenue growth non-GAAP | 9% | Q2 2026 | — |
| Total Company Same-Store Cash NOI year-over-year growth non-GAAP | 10% | Q2 2026 | — |
| Total SHOP Same-Store average occupancy growth non-GAAP | 300 | Q2 2026 | — |
|
|
|||
| U.S. SHOP Same-Store Cash NOI growth non-GAAP | 18% | Q2 2026 | — |
| Unsettled equity forward sales agreements outstanding | 1.6B | Q2 2026 | — |
|
|
|||
| Common stock shares settled under equity forward sales agreements | 10.6M | first quarter 2026 | — |
| Net proceeds from settled equity forward sales agreements | $0.8B | first quarter 2026 | — |
| SHOP Same-Store NOI margin expansion non-GAAP | 170 | first quarter 2026 | — |
| U.S. SHOP Same-Store average occupancy growth non-GAAP | 370 | first quarter 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VTR
this stock
Ventas, Inc.
|
$45.66B | +18.3% | +18.5% | 164.8 | 4.6% |
|
WELL
Welltower Inc.
|
$162.55B | +26.9% | +35.6% | 114.6 | 2.5% |
|
DOC
Healthpeak Properties, Inc.
|
$14.34B | +29.3% | +4.5% | 59.4 | 3.5% |
|
OHI
Omega Healthcare Investors Inc
|
$13.90B | +4.9% | +13.2% | 16.3 | 4.2% |
|
AHR
American Healthcare REIT, Inc.
|
$11.83B | +15.4% | +9.1% | 78.6 | 10.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VTR | -2.0% | -4.8% | +5.7% | -2.1% | +18.3% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -2.4% | -9.2% | -8.1% | -6.1% | +4.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.